Marc D. Normandin

Validating novel tau positron emission tomography tracer <scp>[F‐18]‐AV‐1451 (T807)</scp> on postmortem brain tissue

Marta Marquié, Marc D. Normandin, Charles Vanderburg et al. · Annals of Neurology · 2015 · 626 citations · Full text

Medicine, Neurology, Neuroscience +17

Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study

A Neumeister, Marc D. Normandin, Robert H. Pietrzak et al. · Molecular Psychiatry · 2013 · 358 citations · Full text

Medicine, Neuroscience, Psychiatry +10

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline

Heidi I.L. Jacobs, J. Alex Becker, Kenneth K. Kwong et al. · Science Translational Medicine · 2021 · 240 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis

Deepak Cyril D’Souza, Jose Cortes-Briones, Mohini Ranganathan et al. · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · 2015 · 210 citations

Medicine, Pharmacology, Psychiatry +11

The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography

Justin S. Sanchez, J. Alex Becker, Heidi I.L. Jacobs et al. · Science Translational Medicine · 2021 · 207 citations · Full text

Medicine, Neurology, Neuroscience +17